FOXM1 and cancer: Emerging evidences reveal that transcription factor Forkhead box M1(FOXM1) is involved in chemoresistance, carcinogenesis, and metastasis [7,8], and so suppression of FOXM1 can be a good strategy for cancer therapy [9].